Long COVIDamongBrazilian Adults and Elders 12 Months after Hospital Discharge: A Population-Based Cohort Study
| dc.contributor.author | Maria Aparecida Salci | |
| dc.contributor.author | Lígia Carreira | |
| dc.contributor.author | Natan Nascimento Oliveira | |
| dc.contributor.author | Natan David Pereira | |
| dc.contributor.author | Eduardo Rocha Covre | |
| dc.contributor.author | Giovanna Brichi Pesce | |
| dc.contributor.author | Rosana Rosseto Oliveira | |
| dc.contributor.author | Carla Franciele Höring | |
| dc.contributor.author | Wanessa Cristina Baccon | |
| dc.contributor.author | Jesús Puente Alcaraz | |
| dc.contributor.author | Giovana Alves Santos | |
| dc.contributor.author | Ludmila Lopes Maciel Bolsoni | |
| dc.contributor.author | Andrés Gutiérrez Carmona | |
| dc.contributor.author | João Ricardo Nickenig Vissoci | |
| dc.contributor.author | Luiz Augusto Facchini | |
| dc.contributor.author | Carlos Laranjeira | |
| dc.date.accessioned | 2026-03-09T18:51:05Z | |
| dc.date.available | 2026-03-09T18:51:05Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Abstract: The persistence of symptoms for more than three months following infection with severe acute respiratory syndrome coronavirus 2 is referred to as “Long COVID”. To gain a deeper understanding of the etiology and long-term progression of symptoms, this study aims to analyze the prevalence of Long COVID and its associated factors in a cohort of Brazilian adults and elders, twelve months after hospital discharge. An observational, prospective, and follow-up study was performed with a cohort of adults and older adults diagnosed with COVID-19 in 2020 in the State of Paraná, Brazil. Twelve months after hospital discharge, patients answered a phone questionnaire about the persistence of symptoms after three levels of exposure to COVID-19’s acute phase (ambulatory, medical ward, and intensive care unit). According to the characteristics of participants, the prevalence of Long COVID-19 was calculated, and logistic regression analyses were conducted. We analyzed data from 1822 participants (980 adults [≥18–<60 years] and 842 older people [≥60 years]) across three exposure levels. The overall Long COVID prevalence was 64.2%. Long COVID was observed in 646 adults (55%; of which 326 were women) and 523 older people (45%; of which 284 were women). Females had a higher prevalence of long-term symptoms (52%) compared with men. The most common post-COVID-19 conditions in the 12-month follow-up were neurological (49.8%), followed by musculoskeletal (35.1%) and persistent respiratory symptoms (26.5%). Male individuals were less likely to develop Long COVID (aOR = 0.50). Other determinants were also considered risky, such as the presence of comorbidities (aOR = 1.41). Being an adult and having been hospitalized was associated with the development of Long COVID. The risk of developing Long COVID was twice as high for ward patients (aOR = 2.53) and three times as high for ICU patients (aOR = 3.56) when compared to non-hospitalized patients. Presenting clinical manifestations of digestive (aOR = 1.56), endocrine (aOR = 2.14), cutaneous (aOR = 2.51), musculoskeletal (aOR = 2.76) and psychological systems (aOR = 1.66) made adults more likely to develop Long COVID. Long COVID was present in a large proportion of people affected by the SARS-CoV-2 infection. Presence of Long COVID symptoms displayed a dose–response relationship with the level of disease exposure, with a greater prevalence of symptoms associated with the severe form in the acute period. | |
| dc.description.sponsorship | Ministério da Ciência, Tecnologia, Inovações e Comunicações (FNDCT/MCTIC), Ministério da Saúde (MS) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)—Processo n◦ 402,882/2020-2 FCT—Fundação para a Ciência e a Tecnologia, I.P. (UIDB/05704/2020 and UIDP/05704/2020) and by the Scientific Employment Stimulus—Institutional Call | |
| dc.identifier.doi | 10.3390/healthcare12141443 | |
| dc.identifier.issn | 22279032 | |
| dc.identifier.uri | https://repositorioabierto.uantof.cl/handle/uantof/648 | |
| dc.language.iso | en | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Healthcare (Switzerland) | |
| dc.title | Long COVIDamongBrazilian Adults and Elders 12 Months after Hospital Discharge: A Population-Based Cohort Study | |
| dc.type | Article | |
| oaire.citation.volume | 12 | |
| organization.identifier.ror | Universidad de Antofagasta | |
| uantof.identificator.department | Departamento de Enfermería |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- healthcare-12-01443 (1).pdf
- Tamaño:
- 688.17 KB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed to upon submission
- Descripción: